{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:52:55Z","timestamp":1781646775745,"version":"3.54.5"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100023448","name":"Robert Koch-Institut","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100023448","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Daily oral pre-exposure prophylaxis (PrEP) provides effective protection against HIV. Since September 2019, the costs of PrEP have been covered by statutory health insurance in Germany. While a considerable fraction of PrEP-eligible individuals receives PrEP, coverage is inhomogeneous across Germany. This study aims to identify potential barriers associated with PrEP non-use among PrEP-eligible MSM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Based on the PrApp online cross-sectional study, we analyzed 1,027 PrEP users and 431 PrEP non-users. A PrEP indication was assumed for cis-MSM with a diagnosis of a bacterial STI (syphilis, gonorrhea, chlamydia) or hepatitis C (12 months), \u2265 2 sex partners or sexualized drug use (6 months). Characteristics between PrEP users and PrEP non-users were compared descriptively and using multivariable logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      PrEP non-users were more likely to be aged 18\u201329 years old (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.05, reference group: 30\u201339 years) and to engage in sexualized drug use (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001). The highest HIV-specialists density (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.01, reference group: 6\u20139 HIV-specialists per 10,000 gay men) was associated with PrEP use. Persons with sexualized drug use were more likely to report daily PrEP use as a barrier (34.3% vs. 16.9%, adjusted\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.05). Fear of side effects (54.5%) was the most common barrier and might be more pronounced in PrEP non-users living in a federal state with a high HIV-specialists density (67.9% vs. 51.8%, adjusted\n                      <jats:italic>P<\/jats:italic>\n                      = 0.08). PrEP non-users living in a federal state with a low HIV-specialists density described not wanting to discuss their sex life with their doctor (29.5% vs. 16.0%, adjusted\n                      <jats:italic>P<\/jats:italic>\n                      = 0.08) as a reason for PrEP non-use.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our analyses indicated structural barriers to PrEP use in federal states with a low HIV-specialists density (physician density, non-anonymity). For those with theoretical PrEP access (high HIV-specialists density), fear of side effects could potentially be addressed by effective risk communication.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-026-27039-3","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:36:44Z","timestamp":1774611404000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of potential barriers for PrEP non-users among PrEP-eligible MSM in Germany"],"prefix":"10.1186","volume":"26","author":[{"given":"Helena","family":"Waldorf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Iannuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Albrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Hoebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Gunsenheimer-Bartmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane","family":"Bremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"von\u00a0Kleist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Koppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"27039_CR1","unstructured":"UNAIDS. Global HIV and AIDS statistics - 2024 Fact sheet. 2024. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/UNAIDS_FactSheet_en.pdf. Accessed 6 May 2025."},{"key":"27039_CR2","first-page":"3","volume":"28","author":"M an der Heiden","year":"2024","unstructured":"an der Heiden M, Marcus U, Kollan C, Schmidt D, Koppe U, Gunsenheimer-Bartmeyer B, et al. Estimate of the number of new HIV infections in 2022 and 2023 and the total number of people living with HIV in Germany at the end of 2023. Epid Bull. 2024;28:3\u201320.","journal-title":"Epid Bull"},{"issue":"9903","key":"27039_CR3","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/S0140-6736(13)61998-4","volume":"382","author":"MS Cohen","year":"2013","unstructured":"Cohen MS, Smith MK, Muessig KE, Hallett TB, Powers KA, Kashuba AD. Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? Lancet. 2013;382(9903):1515\u201324.","journal-title":"Lancet"},{"key":"27039_CR4","unstructured":"European Medicines Agency. First medicine for HIV pre-exposure prophylaxis recommended for approval in the EU. 2016. https:\/\/www.ema.europa.eu\/en\/news\/first-medicine-hiv-pre-exposure-prophylaxis-recommended-approval-eu. Accessed 6 May 2025."},{"issue":"27","key":"27039_CR5","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587\u201399.","journal-title":"N Engl J Med"},{"issue":"10246","key":"27039_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0140-6736(20)31065-5","volume":"396","author":"KH Mayer","year":"2020","unstructured":"Mayer KH, Molina JM, Thompson MA, Anderson PL, Mounzer KC, De Wet JJ, et al. Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial. Lancet. 2020;396(10246):239\u201354.","journal-title":"Lancet"},{"issue":"23","key":"27039_CR7","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","volume":"373","author":"JM Molina","year":"2015","unstructured":"Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237\u201346.","journal-title":"N Engl J Med"},{"issue":"13","key":"27039_CR8","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1056\/NEJMoa2411858","volume":"392","author":"CF Kelley","year":"2025","unstructured":"Kelley CF, Acevedo-Qui\u00f1ones M, Agwu AL, Avihingsanon A, Benson P, Blumenthal J, et al. Twice-yearly lenacapavir for HIV prevention in men and gender-diverse persons. N Engl J Med. 2025;392(13):1261\u201376.","journal-title":"N Engl J Med"},{"issue":"7","key":"27039_CR9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1056\/NEJMoa2101016","volume":"385","author":"RJ Landovitz","year":"2021","unstructured":"Landovitz RJ, Donnell D, Clement ME, Hanscom B, Cottle L, Coelho L, et al. Cabotegravir for HIV prevention in cisgender men and transgender women. N Engl J Med. 2021;385(7):595\u2013608.","journal-title":"N Engl J Med"},{"key":"27039_CR10","unstructured":"Deutsche Aidshilfe. PrEP will soon be available for 50 Euros in Germany, starting in seven cities. 2017. https:\/\/www.aidshilfe.de\/de\/meldung\/prep-will-soon-available-50-euros-germany-starting-seven-cities. Accessed 6 May 2025."},{"key":"27039_CR11","unstructured":"AVAC. Global PrEP Tracker. 2024. https:\/\/data.prepwatch.org. Accessed 1 Jul 2025."},{"issue":"5","key":"27039_CR12","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1016\/S2468-2667(25)00062-3","volume":"10","author":"S Bamouni","year":"2025","unstructured":"Bamouni S, de Gage SB, Desplas D, Valbousquet J, Lamant J, Joseph JP, et al. Effect of extending PrEP initiation to primary care settings: a nationwide cohort study in France. Lancet Public Health. 2025;10(5):e362\u201370.","journal-title":"Lancet Public Health"},{"key":"27039_CR13","unstructured":"Bundesgesetzblatt. Gesetz f\u00fcr schnellere Termine und bessere Versorgung (Terminservice- und Versorgungsgesetz\u2013TSVG). 2019. https:\/\/www.gkv-spitzenverband.de\/media\/dokumente\/krankenversicherung_1\/aerztliche_versorgung\/bundesmantelvertrag_1\/bmv_anlagen\/BMV-Ae_Anlage_33_PreP_24-7-2019.pdf. Accessed 6 May 2025."},{"key":"27039_CR14","unstructured":"Bundesministerium f\u00fcr Gesundheit. Schnellere Termine, mehr Sprechstunden, bessere Angebote f\u00fcr gesetzlich Versicherte. In Terminservice- und Versorgungsgesetz (TSVG Terminservice- und Versorgungsgesetz). 2019. https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/3_Downloads\/Gesetze_und_Verordnungen\/GuV\/T\/TSVG_BGBL.pdf. Accessed 6 May 2025."},{"key":"27039_CR15","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s10389-022-01699-y","volume":"31","author":"U Marcus","year":"2023","unstructured":"Marcus U, Schmidt D, Schink SB, Koppe U. Analysis of HIV pre-exposure prophylaxis (PrEP) needs and PrEP use in Germany among men who have sex with men. J Public Health (Berl). 2023;31:1505\u201321.","journal-title":"J Public Health (Berl)"},{"issue":"1","key":"27039_CR16","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1186\/s12889-024-19198-y","volume":"24","author":"D Schmidt","year":"2024","unstructured":"Schmidt D, Duport Y, Kollan C, Marcus U, Iannuzzi S, von Kleist M. Dynamics of HIV PrEP use and coverage during and after COVID-19 in Germany. BMC Public Health. 2024;24(1):1691.","journal-title":"BMC Public Health"},{"key":"27039_CR17","first-page":"100152","volume":"6","author":"KJ Blair","year":"2022","unstructured":"Blair KJ, Torres TS, Hoagland B, Bezerra DR, Veloso VG, Grinsztejn B, et al. Pre-exposure prophylaxis use, HIV knowledge, and internalized homonegativity among men who have sex with men in Brazil: A cross-sectional study. Lancet Reg Health Am. 2022;6:100152.","journal-title":"Lancet Reg Health Am"},{"issue":"3","key":"27039_CR18","doi-asserted-by":"publisher","first-page":"E560","DOI":"10.9778\/cmajo.20220113","volume":"11","author":"OJ Pico-Espinosa","year":"2023","unstructured":"Pico-Espinosa OJ, Hull M, MacPherson P, Grace D, Lachowsky N, Gaspar M, et al. Reasons for not using pre-exposure prophylaxis for HIV and strategies that may facilitate uptake in Ontario and British Columbia among gay, bisexual and other men who have sex with men: a cross-sectional survey. CMAJ Open. 2023;11(3):E560\u20138.","journal-title":"CMAJ Open"},{"issue":"10","key":"27039_CR19","doi-asserted-by":"publisher","first-page":"e25395","DOI":"10.1002\/jia2.25395","volume":"22","author":"U Koppe","year":"2019","unstructured":"Koppe U, Marcus U, Albrecht S, Jansen K, Jessen H, Gunsenheimer-Bartmeyer B, et al. Factors associated with the informal use of HIV pre-exposure prophylaxis in Germany: a cross-sectional study. J Int AIDS Soc. 2019;22(10):e25395.","journal-title":"J Int AIDS Soc"},{"key":"27039_CR20","unstructured":"Deutsche AIDS-Gesellschaft (DAIG). Leitlinie zur Pr\u00e4expositionsprophylaxe (PrEP) zur HIV-Pr\u00e4vention. 2018. https:\/\/daignet.de\/media\/filer_public\/d3\/96\/d3966187-d794-4a19-8e1a-908da78822c5\/leitlinie_prep_055-008_version_1_vom_24-05-2018_konsentiert_22-06-2018.pdf. Accessed 6 Nov 2024."},{"issue":"9","key":"27039_CR21","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1007\/s00103-023-03733-0","volume":"66","author":"D Schmidt","year":"2023","unstructured":"Schmidt D, Kollan C, Schewe K, Hanhoff N, R\u00fcsenberg R, Friebe M, et al. Evaluation der Einf\u00fchrung der HIV-Pr\u00e4expositionsprophylaxe als Leistung der gesetzlichen Krankenversicherung (EvE-PrEP). Bundesgesundheitsbl. 2023;66(9):1008\u201318.","journal-title":"Bundesgesundheitsbl"},{"key":"27039_CR22","unstructured":"dagn\u00e4 e V. Schwerpunktsarztsuche. 2020. https:\/\/www.dagnae.de\/schwerpunktarztsuche. Accessed 20 Jun 2025."},{"key":"27039_CR23","unstructured":"Marcus U, Schink S. Empirische Ergebnisse und Handlungsempfehlungen zur HIV-\/STI-Pr\u00e4vention und Gesundheitsf\u00f6rderung bei schwulen und bisexuellen M\u00e4nnern in Deutschland. EMIS: the European MSM-Internet-Survey 2017 (DAH-Forum Band Nr. 63). Berlin: Deutsche Aidshilfe e.V.; 2022. Available at https:\/\/www.aidshilfe.de\/system\/files\/documents\/emis-2017_national-report_de.pdf"},{"key":"27039_CR24","unstructured":"Bundesinstitut f\u00fcr Bau-, Stadt- und Raumforschung (BBSR). Siedlungsstrukturelle Kreistypen in Deutschland. 2022. https:\/\/www.bbsr.bund.de\/BBSR\/DE\/forschung\/raumbeobachtung\/Raumabgrenzungen\/deutschland\/kreise\/siedlungsstrukturelle-kreistypen\/kreistypen.html. Accessed 18 Nov 2024."},{"key":"27039_CR25","volume-title":"Income distribution in OECD countries: evidence from the Luxembourg Income Study (LIS)","author":"AB Atkinson","year":"1995","unstructured":"Atkinson AB, Rainwater L, Smeeding TM. Income distribution in OECD countries: evidence from the Luxembourg Income Study (LIS). Paris: OECD; 1995."},{"issue":"2","key":"27039_CR26","first-page":"345","volume":"239","author":"J Goebel","year":"2019","unstructured":"Goebel J, Grabka MM, Liebig S, Kroh M, Richter D, Schr\u00f6der C, et al. The German Socio-Economic Panel (SOEP). Jahrb National Stat. 2019;239(2):345\u201360.","journal-title":"Jahrb National Stat"},{"issue":"1","key":"27039_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10508-018-1148-0","volume":"48","author":"BA Feinstein","year":"2019","unstructured":"Feinstein BA, Moran KO, Newcomb ME, Mustanski B. Differences in HIV risk behaviors between self-identified gay and bisexual young men who are HIV-negative. Arch Sex Behav. 2019;48(1):261\u201375.","journal-title":"Arch Sex Behav"},{"issue":"5","key":"27039_CR28","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1521\/aeap.2016.28.5.378","volume":"28","author":"C Grov","year":"2016","unstructured":"Grov C, Rendina HJ, Jimenez R, Parsons JT. Using online settings to identify gay and bisexual men willing to take or with experience taking PrEP: Implications for researchers and providers. AIDS Educ Prev. 2016;28(5):378\u201392.","journal-title":"AIDS Educ Prev"},{"issue":"4","key":"27039_CR29","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1521\/aeap.2010.22.4.356","volume":"22","author":"WL Jeffries 4th","year":"2010","unstructured":"Jeffries WL 4th. HIV testing among bisexual men in the United States. AIDS Educ Prev. 2010;22(4):356\u201370.","journal-title":"AIDS Educ Prev"},{"issue":"1","key":"27039_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12981-021-00386-4","volume":"18","author":"M Pazzini","year":"2021","unstructured":"Pazzini M, Ign\u00e1cz ZS, Tuppat J. Underlying factors related to HIV\/AIDS prevention: investigating the willingness to take pre-exposure prophylaxis among men-who-have-sex-with-men in Germany. AIDS Res Ther. 2021;18(1):61.","journal-title":"AIDS Res Ther"},{"issue":"14","key":"27039_CR31","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1177\/09564624211041456","volume":"32","author":"R Kennedy","year":"2021","unstructured":"Kennedy R, Murira J, Foster K, Heinsbroek E, Keane F, Pal N, et al. Sexualized drug use and specialist service experience among MSM attending urban and rural sexual health clinics in England and Scotland. Int J STD AIDS. 2021;32(14):1338\u201346.","journal-title":"Int J STD AIDS"},{"issue":"4","key":"27039_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11904-022-00608-y","volume":"19","author":"M Viamonte","year":"2022","unstructured":"Viamonte M, Ghanooni D, Reynolds JM, Grov C, Carrico AW. Running with scissors: a systematic review of substance use and the pre-exposure prophylaxis care continuum among sexual minority men. Curr HIV\/AIDS Rep. 2022;19(4):235\u201350.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"27039_CR33","doi-asserted-by":"publisher","first-page":"107526","DOI":"10.1016\/j.drugalcdep.2019.06.028","volume":"206","author":"RCA Achterbergh","year":"2020","unstructured":"Achterbergh RCA, Dr\u00fcckler S, van Rooijen MS, van Aar F, Slurink IAL, de Vries HJC, et al. Sex, drugs, and sexually transmitted infections: A latent class analysis among men who have sex with men in Amsterdam and surrounding urban regions, the Netherlands. Drug Alcohol Depend. 2020;206:107526.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"27039_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/add.14774","volume":"115","author":"RCA Achterbergh","year":"2020","unstructured":"Achterbergh RCA, de Vries HJC, Boyd A, Davidovich U, Dr\u00fcckler S, Hoornenborg E, et al. Identification and characterization of latent classes based on drug use among men who have sex with men at risk of sexually transmitted infections in Amsterdam, the Netherlands. Addiction. 2020;115(1):121\u201333.","journal-title":"Addiction"},{"issue":"12","key":"27039_CR35","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1080\/13691058.2018.1439186","volume":"20","author":"KG Card","year":"2018","unstructured":"Card KG, Armstrong HL, Carter A, Cui Z, Wang L, Zhu J, et al. A latent class analysis of substance use and culture among gay, bisexual and other men who have sex with men. Cult Health Sex. 2018;20(12):1424\u201339.","journal-title":"Cult Health Sex"},{"issue":"1","key":"27039_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1177\/00220426211040564","volume":"52","author":"AD Scholz-Hehn","year":"2022","unstructured":"Scholz-Hehn AD, Milin S, Schulte B, Reimer J, Buth S, Sch\u00e4fer I. Substance use and chemsex in MSM - a latent class analysis. J Drug Issues. 2022;52(1):83\u201396.","journal-title":"J Drug Issues"},{"key":"27039_CR37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.drugpo.2018.01.007","volume":"55","author":"G Melendez-Torres","year":"2018","unstructured":"Melendez-Torres G, Bourne A, Reid D, Hickson F, Bonell C, Weatherburn P. Typology of drug use in United Kingdom men who have sex with men and associations with socio-sexual characteristics. Int J Drug Policy. 2018;55:159\u201364.","journal-title":"Int J Drug Policy"},{"key":"27039_CR38","doi-asserted-by":"publisher","first-page":"107874","DOI":"10.1016\/j.ijid.2025.107874","volume":"154","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Li H, Huang Y, Zhou Z, He Z, Agins B, et al. HIV pre-exposure prophylaxis (PrEP) use among PrEP-eligible men who have sex with men: a systematic review and meta-analysis. Int J Infect Dis. 2025;154:107874.","journal-title":"Int J Infect Dis"},{"key":"27039_CR39","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/s12879-017-2585-4","volume":"17","author":"A Hofmann","year":"2017","unstructured":"Hofmann A, Hauser A, Zimmermann R, Santos-H\u00f6vener C, B\u00e4tzing-Feigenbaum J, Wildner S, et al. Surveillance of recent HIV infections among newly diagnosed HIV cases in Germany between 2008 and 2014. BMC Infect Dis. 2017;17:484.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"27039_CR40","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/00002030-200107060-00013","volume":"15","author":"U Davidovich","year":"2001","unstructured":"Davidovich U, de Wit J, Albrecht N, Geskus R, Stroebe W, Coutinho R. Increase in the share of steady partners as a source of HIV infection: a 17-year study of seroconversion among gay men. AIDS. 2001;15(10):1303\u20138.","journal-title":"AIDS"},{"issue":"6","key":"27039_CR41","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1007\/s10461-020-03109-4","volume":"25","author":"M Basten","year":"2021","unstructured":"Basten M, den Daas C, Heijne JC, Boyd A, Davidovich U, Rozhnova G, et al. The rhythm of risk: sexual behaviour, PrEP use and HIV risk perception between 1999 and 2018 among men who have sex with men in Amsterdam, the Netherlands. AIDS Behav. 2021;25(6):1800\u20139.","journal-title":"AIDS Behav"},{"key":"27039_CR42","doi-asserted-by":"publisher","first-page":"100889","DOI":"10.1016\/j.pmedr.2019.100889","volume":"15","author":"M Caponi","year":"2019","unstructured":"Caponi M, Burgess C, Leatherwood A, Molano LF. Demographic characteristics associated with the use of HIV pre-exposure prophylaxis (PrEP) in an urban, community health center. Prev Med Rep. 2019;15:100889.","journal-title":"Prev Med Rep"},{"issue":"1","key":"27039_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/QAI.0000000000001164","volume":"74","author":"IW Holloway","year":"2017","unstructured":"Holloway IW, Dougherty R, Gildner J, Beougher SC, Pulsipher C, Montoya JA, et al. Brief report: PrEP uptake, adherence, and discontinuation among California YMSM using geosocial networking applications. J Acquir Immune Defic Syndr. 2017;74(1):15\u201320.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"27039_CR44","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.jiph.2022.07.012","volume":"15","author":"P Ahaus","year":"2022","unstructured":"Ahaus P, Schmidt AJ, Skaletz-Rorowski A, Uhrmacher M, Serova K, Kayser A, et al. Changes in the user profiles of HIV pre-exposure prophylaxis (PrEP) before and after PrEP reimbursement. J Infect Public Health. 2022;15(9):955\u201360.","journal-title":"J Infect Public Health"},{"issue":"9","key":"27039_CR45","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1007\/s10461-024-04366-3","volume":"28","author":"S Bonett","year":"2024","unstructured":"Bonett S, Li Q, Sweeney A, Gaither-Hardy D, Safa H. Telehealth models for PrEP delivery: a systematic review of acceptability, implementation, and impact on the PrEP care continuum in the United States. AIDS Behav. 2024;28(9):2875\u201386.","journal-title":"AIDS Behav"},{"issue":"8","key":"27039_CR46","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1080\/09540121.2020.1778626","volume":"32","author":"AS Plomer","year":"2020","unstructured":"Plomer AS, McCool-Myers M, Apfelbacher C. Perspectives on HIV PrEP care in Germany: qualitative insights from primary care physicians and specialists. AIDS Care. 2020;32(8):994\u20131000.","journal-title":"AIDS Care"},{"issue":"12","key":"27039_CR47","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1089\/apc.2017.0082","volume":"31","author":"IW Holloway","year":"2017","unstructured":"Holloway IW, Tan D, Gildner JL, Beougher SC, Pulsipher C, Montoya JA, et al. Facilitators and barriers to pre-exposure prophylaxis willingness among young men who have sex with men who use geosocial networking applications in California. AIDS Patient Care STDS. 2017;31(12):517\u201327.","journal-title":"AIDS Patient Care STDS"},{"issue":"7","key":"27039_CR48","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1080\/13691058.2017.1380230","volume":"20","author":"M Thomann","year":"2018","unstructured":"Thomann M, Grosso A, Zapata R, Chiasson MA. \u2018WTF is PrEP?\u2019: attitudes towards pre-exposure prophylaxis among men who have sex with men and transgender women in New York City. Cult Health Sex. 2018;20(7):772\u201386.","journal-title":"Cult Health Sex"},{"issue":"11","key":"27039_CR49","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1080\/09540121.2017.1300633","volume":"29","author":"S Cahill","year":"2017","unstructured":"Cahill S, Taylor SW, Elsesser SA, Mena L, Hickson D, Mayer KH. Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in black compared to white gay and bisexual men in Jackson, Mississippi and Boston. Massachusetts AIDS Care. 2017;29(11):1351\u20138.","journal-title":"Massachusetts AIDS Care"},{"issue":"9","key":"27039_CR50","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1007\/s10461-014-0845-5","volume":"18","author":"HL King","year":"2014","unstructured":"King HL, Keller SB, Giancola MA, Rodriguez DA, Chau JJ, Young JA, et al. Pre-exposure prophylaxis accessibility research and evaluation (PrEPARE Study). AIDS Behav. 2014;18(9):1722\u20135.","journal-title":"AIDS Behav"},{"issue":"1","key":"27039_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-021-10174-4","volume":"21","author":"U Koppe","year":"2021","unstructured":"Koppe U, Marcus U, Albrecht S, Jansen K, Jessen H, Gunsenheimer-Bartmeyer B, et al. Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany. BMC Public Health. 2021;21(1):1\u201310.","journal-title":"BMC Public Health"},{"issue":"3","key":"27039_CR52","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/COH.0000000000000248","volume":"11","author":"PM Grant","year":"2016","unstructured":"Grant PM, Cotter AG. Tenofovir and bone health. Curr Opin HIV AIDS. 2016;11(3):326\u201332.","journal-title":"Curr Opin HIV AIDS"},{"issue":"22","key":"27039_CR53","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1001\/jama.2019.2591","volume":"321","author":"R Chou","year":"2019","unstructured":"Chou R, Evans C, Hoverman A, Sun C, Dana T, Bougatsos C, et al. Preexposure prophylaxis for the prevention of HIV infection: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2019;321(22):2214\u201330.","journal-title":"JAMA"},{"key":"27039_CR54","unstructured":"Groot Bruinderink ML, Boyd A, Werner L, Jongen VW, Blitz L, van Bokhoven C, et al. Online and Less Frequent Monitoring of Oral HIV PrEP Use Are Noninferior to Standard of Care [CROI Abstract 1206]. Spec Issue Abstr CROI 2025 Conf Retrovir Opportunistic Infect. 2025;33(1):394."},{"key":"27039_CR55","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.drugpo.2019.10.007","volume":"74","author":"C O\u2019Halloran","year":"2019","unstructured":"O\u2019Halloran C, Rice B, White E, Desai M, Dunn DT, McCormack S, et al. Chemsex is not a barrier to self-reported daily PrEP adherence among PROUD study participants. Int J Drug Policy. 2019;74:246\u201354.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"27039_CR56","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s10461-017-1882-7","volume":"22","author":"HJ Badal","year":"2018","unstructured":"Badal HJ, Stryker JE, DeLuca N, Purcell DW. Swipe right: Dating website and app use among men who have sex with men. AIDS Behav. 2018;22(4):1265\u201372.","journal-title":"AIDS Behav"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-27039-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27039-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27039-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:00:17Z","timestamp":1781643617000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-27039-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["27039"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-27039-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8163580\/v1","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"20 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The PrApp study was approved by the ethics commission of the Berlin Chamber of Physicians (Ref: Eth-14\/18). All participants had to provide informed consent through the survey website before starting the survey. The study was conducted in compliance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1170"}}